AAV9
E1555620
UNEXPLORED
AAV9 is a serotype of adeno-associated virus widely used as a gene therapy vector, particularly valued for its ability to efficiently deliver genetic material to cells in the central nervous system and other tissues.
All labels observed (1)
| Label | Occurrences |
|---|---|
| AAV9 canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22796999 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: AAV9 Context triple: [AveXis, usesVector, AAV9]
-
A.
AveXis
AveXis is a biotechnology company best known for developing the gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy.
-
B.
human adenovirus serotype 26 (Ad26)
Human adenovirus serotype 26 (Ad26) is a non-replicating viral vector commonly used in vaccine development to deliver genetic material encoding target antigens and stimulate an immune response.
-
C.
E*Vax
E*Vax is the stage name of Evan Mast, an American electronic musician and producer best known as one half of the duo Ratatat.
-
D.
HCV NS5A protein
HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
-
E.
CAAV
CAAV is the national regulatory body responsible for overseeing and managing civil aviation activities in Vietnam.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: AAV9 Target entity description: AAV9 is a serotype of adeno-associated virus widely used as a gene therapy vector, particularly valued for its ability to efficiently deliver genetic material to cells in the central nervous system and other tissues.
-
A.
AveXis
AveXis is a biotechnology company best known for developing the gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy.
-
B.
human adenovirus serotype 26 (Ad26)
Human adenovirus serotype 26 (Ad26) is a non-replicating viral vector commonly used in vaccine development to deliver genetic material encoding target antigens and stimulate an immune response.
-
C.
E*Vax
E*Vax is the stage name of Evan Mast, an American electronic musician and producer best known as one half of the duo Ratatat.
-
D.
HCV NS5A protein
HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
-
E.
CAAV
CAAV is the national regulatory body responsible for overseeing and managing civil aviation activities in Vietnam.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.